Literature DB >> 22765842

TGFβ-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies.

Elvira Forte1, Fabio Miraldi, Isotta Chimenti, Francesco Angelini, Ann Zeuner, Alessandro Giacomello, Mark Mercola, Elisa Messina.   

Abstract

Autologous cardiac progenitor cells (CPCs) isolated as cardiospheres (CSps) represent a promising candidate for cardiac regenerative therapy. A better understanding of the origin and mechanisms underlying human CSps formation and maturation is undoubtedly required to enhance their cardiomyogenic potential. Epithelial-to-mesenchymal transition (EMT) is a key morphogenetic process that is implicated in the acquisition of stem cell-like properties in different adult tissues, and it is activated in the epicardium after ischemic injury to the heart. We investigated whether EMT is involved in the formation and differentiation of human CSps, revealing that an up-regulation of the expression of EMT-related genes accompanies CSps formation that is relative to primary explant-derived cells and CSp-derived cells grown in a monolayer. EMT and CSps formation is enhanced in the presence of transforming growth factor β1 (TGFβ1) and drastically blocked by the type I TGFβ-receptor inhibitor SB431452, indicating that TGFβ-dependent EMT is essential for the formation of these niche-like 3D-multicellular clusters. Since TGFβ is activated in the myocardium in response to injury, our data suggest that CSps formation mimics an adaptive mechanism that could potentially be enhanced to increase in vivo or ex vivo regenerative potential of adult CPCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22765842      PMCID: PMC4146498          DOI: 10.1089/scd.2012.0277

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  59 in total

Review 1.  Mesp1 expression is the earliest sign of cardiovascular development.

Authors:  Y Saga; S Kitajima; S Miyagawa-Tomita
Journal:  Trends Cardiovasc Med       Date:  2000-11       Impact factor: 6.677

Review 2.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

3.  A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.

Authors:  Sunil K Halder; R Daniel Beauchamp; Pran K Datta
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

4.  Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney.

Authors:  Michael Zeisberg; Amish A Shah; Raghu Kalluri
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

Review 5.  Turning it up a Notch: cross-talk between TGF beta and Notch signaling.

Authors:  Michael Klüppel; Jeffrey L Wrana
Journal:  Bioessays       Date:  2005-02       Impact factor: 4.345

Review 6.  Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.

Authors:  M A Pfeffer; E Braunwald
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

7.  Baf60c is essential for function of BAF chromatin remodelling complexes in heart development.

Authors:  Heiko Lickert; Jun K Takeuchi; Ingo Von Both; Johnathon R Walls; Fionnuala McAuliffe; S Lee Adamson; R Mark Henkelman; Jeffrey L Wrana; Janet Rossant; Benoit G Bruneau
Journal:  Nature       Date:  2004-11-04       Impact factor: 49.962

8.  Isolation and expansion of adult cardiac stem cells from human and murine heart.

Authors:  Elisa Messina; Luciana De Angelis; Giacomo Frati; Stefania Morrone; Stefano Chimenti; Fabio Fiordaliso; Monica Salio; Massimo Battaglia; Michael V G Latronico; Marcello Coletta; Elisabetta Vivarelli; Luigi Frati; Giulio Cossu; Alessandro Giacomello
Journal:  Circ Res       Date:  2004-10-07       Impact factor: 17.367

9.  Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.

Authors:  N J Laping; E Grygielko; A Mathur; S Butter; J Bomberger; C Tweed; W Martin; J Fornwald; R Lehr; J Harling; L Gaster; J F Callahan; B A Olson
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

10.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Authors:  Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

View more
  21 in total

Review 1.  Stem Cell Spheroids and Ex Vivo Niche Modeling: Rationalization and Scaling-Up.

Authors:  Isotta Chimenti; Diana Massai; Umberto Morbiducci; Antonio Paolo Beltrami; Maurizio Pesce; Elisa Messina
Journal:  J Cardiovasc Transl Res       Date:  2017-03-13       Impact factor: 4.132

Review 2.  Developmental origin and lineage plasticity of endogenous cardiac stem cells.

Authors:  Maria Paola Santini; Elvira Forte; Richard P Harvey; Jason C Kovacic
Journal:  Development       Date:  2016-04-15       Impact factor: 6.868

Review 3.  Generation of cardiac progenitor cells through epicardial to mesenchymal transition.

Authors:  Antonia Germani; Eleonora Foglio; Maurizio C Capogrossi; Matteo Antonio Russo; Federica Limana
Journal:  J Mol Med (Berl)       Date:  2015-05-07       Impact factor: 4.599

4.  Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines.

Authors:  Almudena Martinez-Fernandez; Xing Li; Katherine A Hartjes; Andre Terzic; Timothy J Nelson
Journal:  Circ Cardiovasc Genet       Date:  2013-09-14

5.  Analysis of pregnancy-associated plasma protein A production in human adult cardiac progenitor cells.

Authors:  Piera D'Elia; Vittoria Ionta; Isotta Chimenti; Francesco Angelini; Fabio Miraldi; Alessandro Pala; Elisa Messina; Alessandro Giacomello
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

6.  Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.

Authors:  Isotta Chimenti; Roberto Gaetani; Elvira Forte; Francesco Angelini; Elena De Falco; Giuseppe Biondi Zoccai; Elisa Messina; Giacomo Frati; Alessandro Giacomello
Journal:  J Cell Mol Med       Date:  2014-01-20       Impact factor: 5.310

7.  miR-200c-3p Regulates Epitelial-to-Mesenchymal Transition in Epicardial Mesothelial Cells by Targeting Epicardial Follistatin-Related Protein 1.

Authors:  Elena Pontemezzo; Eleonora Foglio; Enza Vernucci; Alessandra Magenta; Marco D'Agostino; Sara Sileno; Elena Astanina; Federico Bussolino; Laura Pellegrini; Antonia Germani; Matteo Antonio Russo; Federica Limana
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

8.  Aging Impairs the Proliferative Capacity of Cardiospheres, Cardiac Progenitor Cells and Cardiac Fibroblasts: Implications for Cell Therapy.

Authors:  Jianqin Ye; Douglas S Hom; Joy Hwang; Yerem Yeghiazarians; Randall J Lee; Andrew J Boyle
Journal:  J Clin Med       Date:  2013-09-23       Impact factor: 4.241

Review 9.  Targeting pleiotropic signaling pathways to control adult cardiac stem cell fate and function.

Authors:  Stefania Pagliari; Jakub Jelinek; Gabriele Grassi; Giancarlo Forte
Journal:  Front Physiol       Date:  2014-07-01       Impact factor: 4.566

10.  THY-1 receptor expression differentiates cardiosphere-derived cells with divergent cardiogenic differentiation potential.

Authors:  Nuria Gago-Lopez; Obinna Awaji; Yiqiang Zhang; Christopher Ko; Ali Nsair; David Liem; April Stempien-Otero; W Robb MacLellan
Journal:  Stem Cell Reports       Date:  2014-04-18       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.